Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Hepatitis C Treatment Snapshots: Daclatasvir
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Stage set for access to Hepatitis C treatment in Malaysia
Part 2: How is hepatitis C treated?
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
